Research Topics
| S J GoldieSummaryAffiliation: Harvard University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Health and economic impact of rotavirus vaccination in GAVI-eligible countriesSun Young Kim
Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
BMC Public Health 10:253. 2010..Our objective was to provide information on the expected health, economic and financial consequences of rotavirus vaccines in the 72 GAVI support-eligible countries...
Cost-effectiveness of Rotavirus vaccination in VietnamSun Young Kim
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
BMC Public Health 9:29. 2009..g., the possibility of reinfection and varying degrees of partial immunity conferred by natural infection), and assess the influence of the features on the cost-effectiveness of rotavirus vaccination...
Economic evaluation of pneumococcal conjugate vaccination in The GambiaSun Young Kim
Department of Health Policy and Management, Harvard School of Public Health, Center for Health Decision Science, Boston, MA, USA
BMC Infect Dis 10:260. 2010..Our objective was to assess the potential impact of PCVs of different valences in The Gambia...
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infectionSue J Goldie
Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts 02115 5924, USA
Am J Med 115:632-41. 2003..To explore the cost-effectiveness of interventions to improve adherence to combination antiretroviral therapy in patients with human immunodeficiency virus (HIV) infection...
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccineSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
J Natl Cancer Inst 96:604-15. 2004..We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 vaccine in a population with an organized cervical cancer screening program...
Health economics and cervical cancer prevention: a global perspectiveSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, 2nd floor Boston, MA 02115 5924, USA
Virus Res 89:301-9. 2002....
Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or moreSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115 5924, USA
Obstet Gynecol 103:619-31. 2004..To evaluate the cost-effectiveness of human papillomavirus (HPV) DNA testing as a primary screening test in combination with cervical cytology in women aged 30 years or more...
A potential error in evaluating cancer screening: a comparison of 2 approaches for modeling underlying disease progressionSue J Goldie
Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
Med Decis Making 23:232-41. 2003..Evaluating cancer screening often requires modeling the underlying disease process and not observed disease, particularly in the absence of direct evidence linking screening to a survival benefit...
A refined estimate of the average lifetime cost of pelvic inflammatory diseaseJennifer M Yeh
Department of Health Policy and Management, Center for Risk Analysis, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115 5924, USA
Sex Transm Dis 30:369-78. 2003..The major complications of pelvic inflammatory disease (infertility, ectopic pregnancy, and chronic pelvic pain) are the leading cause of non-HIV sexually transmitted disease morbidity in the United States...
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccineSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
Int J Cancer 106:896-904. 2003..These include a better understanding of the heterogeneity of vaccine response, the effect of type-specific vaccination on other HPV types and the degree to which vaccination effect persists over time...
Cost-effectiveness of HPV 16, 18 vaccination in BrazilSue J Goldie
Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, United States of America
Vaccine 25:6257-70. 2007....
The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected womenS J Goldie
Center for Risk Analysis, Department of Health Policy and Management, Harvard University School of Public Health, Boston, Massachusetts 02115 5924, USA
Ann Intern Med 130:97-107. 1999..Women with HIV infection have a higher risk for cervical squamous intraepithelial lesions than do women without HIV infection, and the optimal regimen for cervical cancer screening in these women is uncertain...
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive menS J Goldie
Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Mass 02115 5924, USA
JAMA 281:1822-9. 1999..Homosexual and bisexual men infected with human immunodeficiency virus (HIV) are at increased risk for human papillomavirus-related anal neoplasia and anal squamous cell carcinoma (SCC)...
Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectivenessS J Goldie
Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Ave, Suite 2, Boston, MA 02115 5924, USA
JAMA 285:3107-15. 2001..Cervical cancer is a leading cause of cancer-related death among women in developing countries. In such low-resource settings, cytology-based screening is difficult to implement, and less complex strategies may offer additional options...
Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virusS J Goldie
Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115-5924, USA
Am J Med 111:140-9. 2001....
Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adultsB R Schackman
Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Mass, USA
Am J Public Health 91:1456-63. 2001..This study was designed to examine the societal cost-effectiveness and the impact on government payers of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults...
Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significanceJane J Kim
Department of Health Policy and Management, Harvard Center for Risk Analysis, 718 Huntington Ave, Second Floor, Boston, MA 02115, USA
JAMA 287:2382-90. 2002..CONCLUSION: Reflex HPV DNA testing provides the same or greater life expectancy benefits and is more cost-effective than other management strategies for women diagnosed as having ASC-US...
Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectivenessM C Weinstein
Center for Risk Analysis, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115-5924, USA
Ann Intern Med 134:440-50. 2001..Primary resistance testing also seems to be reasonably cost-effective and will become more so as the prevalence of primary resistance increases...
Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectivenessFelicitas C Kuehne
Harvard Program on the Economic Evaluation of Medical Technology, 718 Huntington Ave, Second Floor, Boston, MA 02115-5924, USA
Arch Intern Med 162:2545-56. 2002..CONCLUSIONS: Combination therapy for moderate hepatitis in coinfected patients will increase quality-adjusted life expectancy and have a cost-effectiveness ratio comparable to that of other well-accepted clinical interventions...
Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adultsBruce R Schackman
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
Arch Intern Med 162:2478-86. 2002....
Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and ItalyJane J Kim
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
J Natl Cancer Inst 97:888-95. 2005..CONCLUSIONS: HPV DNA testing has the potential to improve health benefits at a reasonable cost compared with current screening policies in four European countries...
The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource settingJ J Kim
Department of Health Policy and Management, Harvard School of Public Health, Program in Health Decision Science, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
Br J Cancer 97:1322-8. 2007..In a resource-constrained setting such as Brazil, our results support that the first priority in reducing cervical cancer mortality should be to vaccinate pre-adolescent girls...
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDSBruce R Schackman
Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
Med Decis Making 22:27-38. 2002....
The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in MexicoDelphine Hu
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America
PLoS ONE 2:e750. 2007..S. Although national efforts have been made to improve maternal services in the last decade, it is unclear if Millennium Development Goal 5--to reduce maternal mortality by three-quarters by 2015--will be met...
Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United StatesJane J Kim
Department of Health Policy and Management, Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
Ann Intern Med 151:538-45. 2009..The role of vaccination against HPV types 16 and 18, which is recommended routinely for preadolescent girls, is unclear in this age group...
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelinesSue J Goldie
Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Ave, Second Floor, Boston, MA 02115-5924, USA
Arch Intern Med 162:921-8. 2002..quot; In TMP/SMX-intolerant patients, dapsone is more cost-effective than atovaquone...
Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderlyD N Fisman
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, and Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, MA, USA
Clin Infect Dis 32:419-30. 2001..In the absence of prospective clinical trials, debridement and retention is a reasonable strategy for treatment of older persons with staphylococcal or streptococcal infection and a nonloosened prosthesis...
The cost-effectiveness of air bags by seating positionJ D Graham
Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
JAMA 278:1418-25. 1997..Motor vehicle crashes continue to cause significant mortality and morbidity in the United States. Installation of air bags in new passenger vehicles is a major initiative in the field of injury prevention...
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USAH E Hsu
Harvard Medical School, Boston, MA, USA
HIV Med 12:97-108. 2011..The aim of the study was to quantify the benefits (life expectancy gains) and risks (efavirenz-related teratogenicity) associated with using efavirenz in HIV-infected women of childbearing age in the USA...
Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patientsApril D Kimmel
Division of General Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Antivir Ther 10:41-52. 2005..Guidelines regarding the frequency of CD4 cell count and HIV RNA monitoring in HIV-infected patients vary, with recommended strategies ranging from every 2 to every 6 months...
Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysisDelphine Hu
Harvard School of Public Health, Boston, Massachusetts 02115-5924, USA
Ann Intern Med 141:501-13. 2004..trachomatis screening for all women 15 to 29 years of age and selective targeting of those with a history of infection for semiannual screening is very cost-effective compared with other well-accepted clinical interventions...
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalElena Losina
Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America
PLoS Med 6:e1000173. 2009..Our objective was to project the clinical impact and cost-effectiveness of interventions to prevent LTFU from HIV care in West Africa...
HIV drug resistance surveillance for prioritizing treatment in resource-limited settingsRochelle P Walensky
Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
AIDS 21:973-82. 2007..Sentinel testing programs for HIV drug resistance in resource-limited settings can inform policy on antiretroviral therapy (ART) and drug sequencing...
Assessing preferences for prevention versus treatment using willingness to payPhaedra S Corso
Harvard University School of Public Health, USA
Med Decis Making 22:S92-101. 2002..Information from opinion polls suggests citizens favor spending a higher proportion of all health care dollars on prevention rather than treatment...
Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong KongJane J Kim
Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
J Public Health (Oxf) 26:130-7. 2004..CONCLUSIONS: Compared with the status quo of opportunistic screening, adopting a policy of organized, mass cervical screening in Hong Kong can substantially increase benefits and reduce costs...
Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patientsKenneth A Freedberg
Divisions of General Medicine and Infectious Diseases and the Partners AIDS Research Center, Massachusetts General Hospital, Boston, MA 02114, USA
J Acquir Immune Defic Syndr 43:S113-8. 2006..Adherence interventions with modest effectiveness are likely to provide long-term survival benefit to patients and to be cost-effective compared with other uses of HIV care funds...
Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico CityD Hu
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
BJOG 116:768-79. 2009....
Preference-based measures in economic evaluation in health careP J Neumann
Program on the Economic Evaluation of Medical Technology, Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts 02115, USA
Annu Rev Public Health 21:587-611. 2000..Widespread acceptance of the methodology likely awaits more consensus on measurement techniques, as well as educational efforts in the public health and medical communities on the usefulness of the approach...
Mathematical models of cervical cancer prevention in Latin America and the CaribbeanSue J Goldie
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
Vaccine 26:L59-72. 2008..If the cost per vaccinated girl is less than I$25 HPV-16/18 vaccination would be very cost-effective in all 33 countries; for it to be affordable, costs may need to be lower...
Mathematical models of cervical cancer prevention in the Asia Pacific regionSue J Goldie
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
Vaccine 26:M17-29. 2008....
Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIVNicole G Campos
Program in Health Policy, Harvard University, Cambridge, Mass, USA
Am J Med 120:272-9. 2007..Our objective was to use these data to examine the cost-effectiveness of treating HCV in an urban cohort of co-infected patients...
Packaging health services when resources are limited: the example of a cervical cancer screening visitJane J Kim
Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America
PLoS Med 3:e434. 2006....
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'IvoireSue J Goldie
Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
N Engl J Med 355:1141-53. 2006..As antiretroviral therapy is increasingly used in settings with limited resources, key questions about the timing of treatment and use of diagnostic tests to guide clinical decisions must be addressed...
Modeling cervical cancer prevention in developed countriesJane J Kim
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
Vaccine 26:K76-86. 2008..The objective of this review is to highlight points of consensus and qualitative themes, to discuss the areas of divergent findings, and to provide insight into critical decisions related to cervical cancer prevention...
Multiparameter calibration of a natural history model of cervical cancerJane J Kim
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
Am J Epidemiol 166:137-50. 2007..The authors found that leveraging primary data from longitudinal studies provides unique opportunities for model parameterization of the unobservable nature of HPV infection and its role in the development of cervical cancer...
Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccinationJeremy D Goldhaber-Fiebert
Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
Popul Health Metr 5:11. 2007..S. policy choices for cervical cancer prevention, we developed a model of human papillomavirus (HPV) and cervical cancer, explicitly incorporating uncertainty about the natural history of disease...
Trade-offs in cervical cancer prevention: balancing benefits and risksNatasha K Stout
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Ave, Second Floor, Boston, MA 02115, USA
Arch Intern Med 168:1881-9. 2008....
Health and economic implications of HPV vaccination in the United StatesJane J Kim
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
N Engl J Med 359:821-32. 2008..The cost-effectiveness of prophylactic vaccination against human papillomavirus types 16 (HPV-16) and 18 (HPV-18) is an important consideration for guidelines for immunization in the United States...
Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan AfricaChara E Rydzak
MD PhD Program in Health Policy, Harvard Medical School, Boston, MA 02115, USA
Sex Transm Dis 35:775-84. 2008..We assess the cost-effectiveness of on-site prenatal syphilis screening with newly available rapid point-of-care screening tests in sub-Saharan Africa...
Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policyJane J Kim
Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
Vaccine 26:4015-24. 2008..e., <$5 per dose), and screening is offered at older ages...
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesSue J Goldie
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
Vaccine 26:4080-93. 2008....
Development of an empirically calibrated model of gastric cancer in two high-risk countriesJennifer M Yeh
Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
Cancer Epidemiol Biomarkers Prev 17:1179-87. 2008..As better data become available, the model can be refined and recalibrated, and, as such, be used as an iterative tool to assess the likely health and economic outcomes associated with gastric cancer prevention strategies...
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implicationsSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
Reprod Health Matters 16:86-96. 2008..Concerns about financial costs and affordability highlight the need for lowering vaccine prices, cost-efficient mechanisms for delivery of vaccinations to adolescents, and creative sources of financing...
Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial resultsJennifer M Yeh
Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
Int J Cancer 124:157-66. 2009..These results illustrate the potential promise of a gastric cancer screening program and provide rationale for urgent clinical studies to move the prevention agenda forward...
Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curvesSun Young Kim
Program in Health Decision Science, Health Policy and Management Department, Harvard School of Public Health, Boston, MA 02115, USA
Bull World Health Organ 85:833-42. 2007..We sought to describe a method that explicitly considers both a health-care programmes cost-effectiveness and its affordability. For illustration, we apply the method to the programme to vaccinate infants against hepatitis B in the Gambia...
Keeping the noise down: common random numbers for disease simulation modelingNatasha K Stout
Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Ave, Boston, MA 02115, USA
Health Care Manag Sci 11:399-406. 2008..We provide a tutorial introduction and demonstrate the application of common random numbers in an individual-level simulation model of the epidemiology of breast cancer...
Chapter 19: Cost-effectiveness of cervical cancer screeningSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
Vaccine 24:S3/164-70. 2006..Despite differences in methods and assumptions, this paper identifies the qualitative themes that are consistent among studies, and highlights important methodological challenges and high-priority areas for further work...
Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancerJennifer M Yeh
Center for Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
Cancer 116:2941-53. 2010..The objective of this study was to estimate the clinical benefits and cost-effectiveness of treatment and endoscopic surveillance to prevent gastric cancer...
Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV diseasePaul E Sax
Division of Infectious Disease and the Partners AIDS Research Center, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Acquir Immune Defic Syndr 39:69-77. 2005..Because of the high cost of ENF compared with other antiretroviral agents, our objectives were to determine the potential long-term clinical impact and cost-effectiveness of ENF in these patients...
Scaling up antiretroviral therapy in South Africa: the impact of speed on survivalRochelle P Walensky
The Divisions of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
J Infect Dis 197:1324-32. 2008..Only 33% of eligible human immunodeficiency virus (HIV)-infected patients in South Africa receive antiretroviral therapy (ART). We sought to estimate the impact of alternative ART scale-up scenarios on patient outcomes from 2007-2012...
Taking account of future technology in cost effectiveness analysisJoshua A Salomon
Department of Population and International Health, Harvard School of Public Health, Harvard Center for Population and Development Studies, 9 Bow Street, Cambridge MA 02138, USA
BMJ 329:733-6. 2004
Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient populationJoshua A Salomon
Harvard Center for Population and Development Studies, Cambridge, Mass 02138, USA
JAMA 290:228-37. 2003..Approximately 2.7 million US individuals are chronically infected with the hepatitis C virus (HCV). As public health campaigns are pursued, a growing number of treatment candidates are likely to have minimal evidence of liver damage...
A therapeutic HIV vaccine: how good is good enough?Rochelle P Walensky
Department of Medicine, Massachusetts General Hospital, and the Partners AIDS Research Center, Harvard Medical School, Boston, MA 02114, USA
Vaccine 22:4044-53. 2004..91 months (cost-effectiveness ratio US$ 45,500/QALY). Even modestly effective therapeutic HIV vaccines may produce small but meaningful increases in life expectancy and compare favorably to alternative uses of scarce HIV care resources...
Alternative strategies to reduce maternal mortality in India: a cost-effectiveness analysisSue J Goldie
Center for Health Decision Science, Harvard School of Public Health, Boston, Massachusetts, United States of America
PLoS Med 7:e1000264. 2010....
Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in VietnamSun Young Kim
Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
Med Decis Making 30:E1-E28. 2010....
The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortalityGeorge R Seage
Department of Epidemiology and Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115, USA
J Acquir Immune Defic Syndr 30:421-8. 2002....
Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projectionsJennifer M Yeh
Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
Cancer Causes Control 20:2021-9. 2009..Our aim was to (1) retrospectively estimate the effects of Helicobacter pylori (H. pylori) and smoking on past gastric cancer incidence and (2) project how interventions on these two risk factors can reduce future incidence...
Cost-effectiveness of cervical-cancer screening in five developing countriesSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
N Engl J Med 353:2158-68. 2005..Cervical-cancer screening strategies that involve the use of conventional cytology and require multiple visits have been impractical in developing countries...
Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modelingSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
Vaccine 24:S3/155-63. 2006....
Assessing the sensitivity of decision-analytic results to unobserved markers of risk: defining the effects of heterogeneity biasKaren M Kuntz
Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
Med Decis Making 22:218-27. 2002..This analysis provides a general framework to determine when issues of heterogeneity may be important...
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United StatesJane J Kim
Harvard School of Public Health, Department of Health Policy and Management, Center for Health Decision Science, 718 Huntington Avenue, Boston, MA 02115, USA
BMJ 339:b3884. 2009..To assess the cost effectiveness of including preadolescent boys in a routine human papillomavirus (HPV) vaccination programme for preadolescent girls...
The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategiesDelphine Hu
Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02138, USA
Sex Transm Dis 33:428-36. 2006..To understand the potential impact of assumptions about the natural history of untreated Chlamydia trachomatis on the cost-effectiveness of screening strategies...
Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'IvoireE Losina
Departments of Biostatistics and Epidemiology, School of Public Health, Boston University, Boston, MA, USA
S Afr Med J 96:526-9. 2006..To estimate incidence rates of opportunistic diseases (ODs) and mortality for patients with and without a history of OD among HIV-infected patients in Côte d'Ivoire...
Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysisPaul E Sax
Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
Clin Infect Dis 41:1316-23. 2005..Our objective was to determine the clinical impact and cost-effectiveness of genotype resistance testing for treatment-naive patients with chronic HIV infection...
Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapyRochelle P Walensky
Division of Infectious Disease and the Partners AIDS Research Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA
J Acquir Immune Defic Syndr 31:27-37. 2002..These results can assist decision makers and those planning clinical trials in defining evidence-based performance measures for primary HIV infection treatment and future trials...
The cost effectiveness of gonorrhea screening in urban emergency departmentsJulia E Aledort
Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
Sex Transm Dis 32:425-36. 2005..The prevalence of gonorrhea (GC) among adolescent and young women attending some urban emergency departments (EDs) ranges from 1% to 7%, but historically screening has not been logistically practical...
Predictors of hazardous child seating behavior in fatal motor vehicle crashes: 1990 to 1998E Wittenberg
Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts, USA
Pediatrics 108:438-42. 2001..This study identifies factors associated with the seating of children in the front seats of vehicles involved in fatal crashes between 1990 and 1998...
Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgeryG Zanetti
Channing Laboratory, Brigham and Women s Hospital, and Eastern Massachusetts CDC Prevention Epicenter, Boston, USA
Emerg Infect Dis 7:820-7. 2001..Data on vancomycin's impact on resistance are needed to quantify the trade-off between individual patients' improved clinical outcomes and lower costs and the future long-term consequences to society...
State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standardsMira Johri
Department of Health Administration, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada
Med Care 40:429-41. 2002..The 54 state AIDS Drug Assistance Programs (ADAP) provide medications to HIV-infected persons with limited resources. Eligibility and coverage vary, raising concerns about health inequities...
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccinationJeremy D Goldhaber-Fiebert
Doctoral Program in Health Policy, Decision Science Concentration, Harvard University, Cambridge, MA, USA
J Natl Cancer Inst 100:308-20. 2008....
Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United StatesDavid N Fisman
City of Hamilton Social and Public Health Services Department, McMaster University, Hamilton, Ontario, Canada
Sex Transm Dis 29:608-22. 2002....
Lifetime cost of HIV care in France during the era of highly active antiretroviral therapyYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille, France
Antivir Ther 7:257-66. 2002..To estimate the treatment and health care costs of HIV infection or AIDS in France during the era of highly active antiretroviral therapy (HAART)...
The cost-effectiveness of elective Cesarean delivery to prevent hepatitis C transmission in HIV-coinfected womenBruce R Schackman
Divisions of Outcomes and Effectiveness, Department of Public Health, Weill Medical College of Cornell University, New York, NY 10021, USA
AIDS 18:1827-34. 2004....
HPV communication: review of existing research and recommendations for patient educationRebecca Anhang
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
CA Cancer J Clin 54:248-59. 2004....
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysisYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille, France
AIDS 19:1299-308. 2005..In 2000, WHO/UNAIDS recommended co-trimoxazole prophylaxis for persons at early stages of HIV infection (WHO stage > or = 2) in sub-Saharan Africa...
Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United StatesCaroline T Korves
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
PLoS Med 3:e21. 2006..WNV can be transmitted by blood transfusion, and mandatory screening of blood for WNV was recently introduced throughout the US. Guidelines for selecting cost-effective strategies for screening blood for WNV do not exist...
Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS)Shalini L Kulasingam
Department of Obstetrics and Gynecology, Duke University, Durham, NC, USA
J Natl Cancer Inst 98:92-100. 2006..We conducted a cost-effectiveness analysis of the ALTS trial to determine whether HPV DNA testing is a cost-effective alternative to immediate colposcopy or conservative management with up to three cytology examinations...
The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in GermanyUwe Siebert
Department of Public Health, Medical Decision Making and Health Technology Assessment, UMIT University of Health Sciences, Medical Informatics and Technology, Hall i T, Austria
Eur J Public Health 16:185-92. 2006..We sought to develop and validate a decision-analytic model for the natural history of cervical cancer for the German health care context and to apply it to cervical cancer screening...
Introducing HPV vaccine in developing countries--key challenges and issuesJan M Agosti
Global Health Program, Bill and Melinda Gates Foundation, Seattle, USA
N Engl J Med 356:1908-10. 2007
Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancerJanice S Kwon
Department of Obstetrics and Gynecology, University of Western Ontario, London
J Obstet Gynaecol Can 29:131-9. 2007..We evaluated the cost-effectiveness of two common strategies for managing early endometrial cancer as part of an Ontario population-based study...
Empirically calibrated model of hepatitis C virus infection in the United StatesJoshua A Salomon
Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
Am J Epidemiol 156:761-73. 2002..These findings have important implications both for individual clinical decisions and for broader public health policy...
Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmesGeoffrey P Garnett
Department of Infectious Disease Epidemiology, Imperial College London, St Mary s Campus, Norfolk Place, London, UK
Vaccine 24:S3/178-86. 2006..To date, model results are consistent in predicting a useful role for vaccine, but further epidemiological data are required to help test the validity of models...
Economic evaluation of weight loss interventions in overweight and obese womenLarissa Roux
Department of Community Health Sciences, University of Calgary, Canada
Obesity (Silver Spring) 14:1093-106. 2006..To conduct a clinical and economic evaluation of outpatient weight loss strategies in overweight and obese adult U.S. women...
Budget impact of Medicaid Section 1115 demonstrations for early HIV treatmentBruce R Schackman
Weill Medical College of Cornell University, New York, NY 10021, USA
Health Care Financ Rev 26:67-80. 2005....
Rationing decisions and individual responsibility for illness: are all lives equal?Eve Wittenberg
MGH Institute for Technology Assessment, Massachusetts General Hospital, Boston 02114, USA
Med Decis Making 23:194-211. 2003..This survey measured individuals' rationing allocation choices for situations in which patients are deemed to hold personal responsibility for their diseases and the influence of different arguments on such choices...
Blood screening for west nile virus: the cost-effectiveness of a real-time, trigger-based strategyCaroline T Korves
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
Clin Infect Dis 43:490-3. 2006..A newly proposed, real-time, trigger-based screening strategy was analyzed and was also shown to be not cost-effective. These results were highly sensitive to pricing of screening assays...
News media coverage of human papillomavirusRebecca Anhang
Harvard Center for Risk Analysis, Harvard School of Public Health, 718 Huntington Avenue, Suite 2, Boston, MA 02115-5924, USA
Cancer 100:308-14. 2004....
Research Grants
- Clinical & Cost-Effectiveness of Cervical CA ScreeningSue Goldie; Fiscal Year: 2004..The proposed analyses will provide important information to clinicians, public health providers, and policy makers in both the national and international arena. ..
- Clinical & Cost Effectiveness of HPV Vaccination in the USSue Goldie; Fiscal Year: 2009....
- Clinical & Cost Effectiveness of HPV Vaccination in the USSue Goldie; Fiscal Year: 2009....
